Cancer Immunotherapy Explained: PD-1, PD-L1, CTLA-4, Checkpoint Inhibitors and Immune Side Effects | How the Immune System Fights Cancer

See How the Immune System Fights Cancer with a focused overview of cancer immunotherapy, immune checkpoint inhibitors, and PD-1 PD-L1 blockade. Key points include CTLA-4 inhibitors, immune related adverse events, and immuno-oncology, with practical context for diagnosis, treatment sequencing, expected outcomes, and follow-up. The video is especially relevant to people searching for cancer immunotherapy, CTLA-4 inhibitors, or immune related adverse events and wanting a clearer explanation of how oncologists make treatment decisions. Useful for patients comparing treatment choices and preparing questions for an oncology consultation. Ask the treating team how these principles apply to the specific cancer diagnosis. Modern oncology